These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3299354)

  • 1. [Polysomnographic measurements in early and late administration (18.00 vs. 22.00 hours) of retarded theophylline in bronchial asthma].
    Rühle KH; Horn H; Hagenmeier A; Würtemberger G; Schmitz-Schumann M; Matthys H
    Prax Klin Pneumol; 1987 May; 41(5):180-6. PubMed ID: 3299354
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of nocturnal bronchial asthma: comparison of various doses of retard theophylline].
    Dorow P; Steinijans VW
    Prax Klin Pneumol; 1987 Oct; 41(10):442-4. PubMed ID: 3325964
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnosis and therapy of nocturnal asthma].
    Kirsten D; Mäder I; Kummer F; Klech H
    Z Gesamte Inn Med; 1987 Oct; 42(19):559-63. PubMed ID: 3424888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Obstructive airway diseases. Basic therapy with pure theophylline in retard form].
    Pollert I
    Fortschr Med; 1982 Mar; 100(12):547-50. PubMed ID: 7042500
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trial of a sustained release theophylline tablet in adult asthmatics.
    Dhand R; Malik SK; Garg SK; Bhutani JK; Swaminathan S
    Indian J Chest Dis Allied Sci; 1986; 28(4):212-21. PubMed ID: 3301644
    [No Abstract]   [Full Text] [Related]  

  • 7. [Efficiency and safety of anhydrous theophylline in delayed-release microspheres in the treatment of bronchial asthma].
    Huerta JG; Moguel A
    Rev Alerg Mex (1987); 1988; 35(2):41-6. PubMed ID: 3389490
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative trial of the clinical efficacy and pharmacokinetics of 12-hour and 24-hour controlled release theophylline preparations in patients with chronic asthma.
    Tinkelman DG; Miller E; Janky DG; Decouto J; Edelman L
    Ann Allergy; 1985 Oct; 55(4):571-6. PubMed ID: 3901832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prescription of Theostat 300 as a single evening dose].
    Germouty J; Bida C; Moreau L
    Rev Pneumol Clin; 1987; 43(5):262-5. PubMed ID: 3324266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study comparing Pro-Vent and phyllocontin in stable asthmatics.
    Sivananthan N; Kana D; Winson MD; Roberts KN
    Br J Clin Pract; 1988 Dec; 42(12):498-500. PubMed ID: 3076785
    [No Abstract]   [Full Text] [Related]  

  • 11. [A comparative study of Unixan administered once daily and Theo-Dur administered twice daily].
    Dahl R; Pedersen B
    Ugeskr Laeger; 1986 Sep; 148(40):2548-51. PubMed ID: 3535197
    [No Abstract]   [Full Text] [Related]  

  • 12. Nifedipine and pulmonary functions in bronchial asthma.
    Sharma SK; Pande JN; Guleria JS
    J Assoc Physicians India; 1988 May; 36(5):350-1. PubMed ID: 3053634
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
    Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M
    Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preliminary results of a new delayed-action theophylline preparation (1 dose in 24 hours) in the treatment of childhood asthma].
    Ciofetta G; Indinnimeo L; De Castro G; Lo Tesoriere A; Barretta MA; Lalia F; Zicari AM; Ronchetti R
    Minerva Pediatr; 1986 Oct; 38(19):843-8. PubMed ID: 3796546
    [No Abstract]   [Full Text] [Related]  

  • 15. [Long-term study on a new beta2-sympathicomimetic agent and a combination of an oral theophylline-ethylenediamine with retard effect and hexoprenaline (author's transl)].
    Dorow P
    Arzneimittelforschung; 1979; 29(1):145-7. PubMed ID: 375946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled-release theophylline and proxyphylline in asthmatics: a comparative study.
    Mosbech H; Paulsen H; Søborg M
    Pharmatherapeutica; 1984; 3(9):626-30. PubMed ID: 6374684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of a new delayed-release anhydrous theophylline by single daily administration in the treatment of reversible bronchial obstruction. Comparison with a delayed-release preparation administered twice daily].
    Baronti A; Verdiani P; Di Carlo S
    Clin Ter; 1987 Sep; 122(6):437-40. PubMed ID: 2972456
    [No Abstract]   [Full Text] [Related]  

  • 18. The efficacy of sustained release theophylline (Pro-Vent), in asthma.
    Wallis PJ; Joy M; Hughes DT; Empey DW
    Br J Clin Pract; 1985 Sep; 39(9):341-5. PubMed ID: 3904796
    [No Abstract]   [Full Text] [Related]  

  • 19. [Theophylline: new information about a proven drug. The dual effect in therapy of bronchial asthma].
    Ukena D; Keller A; Sybrecht GW
    Med Klin (Munich); 1994 Dec; 89(12):668-74. PubMed ID: 7870002
    [No Abstract]   [Full Text] [Related]  

  • 20. [Individualized therapy of protracted attacks of bronchial asthma using theophylline preparations].
    Tsoĭ AN; Gavrilenko LN; Bogovskiĭ VP; Semenova LG; Antonovskiĭ IuA
    Sov Med; 1990; (6):77-81. PubMed ID: 2396131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.